NOD2‐Associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in spain
Authors:
- Carlos D. RoséCRCarlos D. Rosé
- Juan I. ArósteguiJAJuan I. Aróstegui
- Lisabeth ScalziLSLisabeth Scalzi
- James T. RosenbaumJRJames T. Rosenbaum
Open Access
- 28 May 2009
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (6) , 1797-1803
Abstract
Objective: To study the phenotype characteristics of the largest to date cohort of patients with pediatric granulomatous arthritis (PGA) and documented mutations in the NOD2 gene.Methods: We analyzed merged data from 2 prospective cohorts of PGA patients, the International PGA Registry and a Spanish cohort. A systematic review of the medical records of interest was performed to identify phenotype characteristics.Results: Forty‐five patients with PGA (23 sporadic cases and 22 from familial pedigrees) and documented NOD2 mutations were identified and formed the basis of the study. Of these 45 patients, 18 had the R334W‐encoding mutation, 18 had R334Q, 4 had E383K, 3 had R587C, 1 had C495Y, and 1 had W490L. The majority of patients manifested the typical triad of dermatitis, uveitis, and arthritis. In contrast, in 13 patients, the following “atypical” manifestations were noted: fever, sialadenitis, lymphadenopathy, erythema nodosum, leukocytoclastic vasculitis, transient neuropathy, granulomatous glomerular and interstitial nephritis, interstitial lung disease, arterial hypertension, hypertrophic cardiomyopathy, pericarditis, pulmonary embolism, hepatic granulomatous infiltration, splenic involvement, and chronic renal failure. In addition, 4 individuals who were asymptomatic carriers of a disease‐causing mutation were documented.Conclusion: NOD2‐associated PGA can be a multisystem disorder with significant visceral involvement. Treating physicians should be aware of the systemic nature of this condition, since some of these manifestations may entail long‐term morbidity.Keywords
This publication has 23 references indexed in Scilit:
- Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigreeArthritis & Rheumatism, 2009
- NOD2 gene–associated pediatric granulomatous arthritis: Clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin‐1 blockade in a Spanish cohortArthritis & Rheumatism, 2007
- Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15Arthritis & Rheumatism, 2007
- Pediatric granulomatous arthritis: An international registryArthritis & Rheumatism, 2006
- Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: A low‐penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versaArthritis & Rheumatism, 2004
- CARD15 mutations in familial granulomatosis syndromes: A study of the original Blau syndrome kindred and other families with large‐vessel arteritis and cranial neuropathyArthritis & Rheumatism, 2002
- Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cystsThe Journal of Pediatrics, 1990
- Vasculopathy with renal artery stenosis in a child with sarcoidosisThe Journal of Pediatrics, 1986
- Familial granulomatous arthritis, iritis, and rashThe Journal of Pediatrics, 1985
- Familial Granulomatous Arteritis with Polyarthritis of Juvenile OnsetNew England Journal of Medicine, 1982